View in EDS

SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy.

Saved in:
Bibliographic Details
Title: SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy.
Authors: Zhao XY; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Zhengzhou University, Zhengzhou, Henan, China., Li SS; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Zhengzhou University, Zhengzhou, Henan, China.; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.; Ministry of Education of China, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, Henan, China., He YX; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Zhengzhou University, Zhengzhou, Henan, China.; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.; Ministry of Education of China, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, Henan, China., Yan LJ; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Zhengzhou University, Zhengzhou, Henan, China.; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.; Ministry of Education of China, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, Henan, China., Lv F; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Zhengzhou University, Zhengzhou, Henan, China., Liang QM; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Zhengzhou University, Zhengzhou, Henan, China., Gan YH; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Zhengzhou University, Zhengzhou, Henan, China.; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.; Ministry of Education of China, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, Henan, China., Han LP; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Zhengzhou University, Zhengzhou, Henan, China., Xu HD; Zhengzhou University, Zhengzhou, Henan, China.; Ministry of Education of China, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, Henan, China., Li YC; Zhengzhou University, Zhengzhou, Henan, China.; Ministry of Education of China, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, Henan, China., Qi YY; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China qqyyiillyy@126.com.; Zhengzhou University, Zhengzhou, Henan, China.; Laboratory of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou Henan, China.
Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2023 Oct; Vol. 82 (10), pp. 1328-1340. Date of Electronic Publication: 2023 Jul 24.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic) Linking ISSN: 00034967 NLM ISO Abbreviation: Ann Rheum Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37487609
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zhao+XY%22">Zhao XY</searchLink>; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Zhengzhou University, Zhengzhou, Henan, China.<br /><searchLink fieldCode="AU" term="%22Li+SS%22">Li SS</searchLink>; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Zhengzhou University, Zhengzhou, Henan, China.; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.; Ministry of Education of China, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, Henan, China.<br /><searchLink fieldCode="AU" term="%22He+YX%22">He YX</searchLink>; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Zhengzhou University, Zhengzhou, Henan, China.; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.; Ministry of Education of China, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, Henan, China.<br /><searchLink fieldCode="AU" term="%22Yan+LJ%22">Yan LJ</searchLink>; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Zhengzhou University, Zhengzhou, Henan, China.; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.; Ministry of Education of China, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, Henan, China.<br /><searchLink fieldCode="AU" term="%22Lv+F%22">Lv F</searchLink>; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Zhengzhou University, Zhengzhou, Henan, China.<br /><searchLink fieldCode="AU" term="%22Liang+QM%22">Liang QM</searchLink>; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Zhengzhou University, Zhengzhou, Henan, China.<br /><searchLink fieldCode="AU" term="%22Gan+YH%22">Gan YH</searchLink>; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Zhengzhou University, Zhengzhou, Henan, China.; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.; Ministry of Education of China, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, Henan, China.<br /><searchLink fieldCode="AU" term="%22Han+LP%22">Han LP</searchLink>; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Zhengzhou University, Zhengzhou, Henan, China.<br /><searchLink fieldCode="AU" term="%22Xu+HD%22">Xu HD</searchLink>; Zhengzhou University, Zhengzhou, Henan, China.; Ministry of Education of China, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, Henan, China.<br /><searchLink fieldCode="AU" term="%22Li+YC%22">Li YC</searchLink>; Zhengzhou University, Zhengzhou, Henan, China.; Ministry of Education of China, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, Henan, China.<br /><searchLink fieldCode="AU" term="%22Qi+YY%22">Qi YY</searchLink>; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China qqyyiillyy@126.com.; Zhengzhou University, Zhengzhou, Henan, China.; Laboratory of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou Henan, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220372355%22">Annals of the rheumatic diseases</searchLink> [Ann Rheum Dis] 2023 Oct; Vol. 82 (10), pp. 1328-1340. <i>Date of Electronic Publication: </i>2023 Jul 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372355 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1468-2060 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200034967%22">00034967 </searchLink><i>NLM ISO Abbreviation: </i>Ann Rheum Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37487609
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/ard-2023-224242
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1328
    Titles:
      – TitleFull: SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zhao XY
      – PersonEntity:
          Name:
            NameFull: Li SS
      – PersonEntity:
          Name:
            NameFull: He YX
      – PersonEntity:
          Name:
            NameFull: Yan LJ
      – PersonEntity:
          Name:
            NameFull: Lv F
      – PersonEntity:
          Name:
            NameFull: Liang QM
      – PersonEntity:
          Name:
            NameFull: Gan YH
      – PersonEntity:
          Name:
            NameFull: Han LP
      – PersonEntity:
          Name:
            NameFull: Xu HD
      – PersonEntity:
          Name:
            NameFull: Li YC
      – PersonEntity:
          Name:
            NameFull: Qi YY
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2023 Oct
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1468-2060
          Numbering:
            – Type: volume
              Value: 82
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Annals of the rheumatic diseases
              Type: main
ResultId 1